Free Trial

Cryo-Cell International, Inc. Announces Quarterly Dividend of $0.25 (NYSEAMERICAN:CCEL)

Cryo-Cell International logo with Medical background

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL - Get Free Report) declared a quarterly dividend on Wednesday, January 29th,Wall Street Journal reports. Shareholders of record on Friday, February 14th will be paid a dividend of 0.25 per share on Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a yield of 13.21%. The ex-dividend date of this dividend is Friday, February 14th.

Cryo-Cell International has a payout ratio of 370.4% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments.

Cryo-Cell International Stock Down 2.8 %

CCEL stock traded down $0.22 during trading on Monday, hitting $7.57. 14,714 shares of the stock traded hands, compared to its average volume of 10,558. The company has a market capitalization of $61.01 million, a P/E ratio of -7.14 and a beta of 0.53. Cryo-Cell International has a one year low of $4.47 and a one year high of $9.50.

Cryo-Cell International Company Profile

(Get Free Report)

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.

Featured Articles

Should You Invest $1,000 in Cryo-Cell International Right Now?

Before you consider Cryo-Cell International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cryo-Cell International wasn't on the list.

While Cryo-Cell International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines